Navigation Links
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Date:3/17/2009

ed in the study. The incidence of mania, hypomania, depression and suicidal ideation were comparable between the NUVIGIL and placebo groups. There were two serious adverse events of mania in the placebo group but none in the NUVIGIL group. Other adverse events that occurred more frequently in the NUVIGIL versus the placebo group included restlessness and anxiety.

Cephalon is preparing to launch NUVIGIL, the longer-lasting isomer of modafinil, in the third quarter of 2009. NUVIGIL is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work sleep disorder, also known as shift work disorder (SWD), and narcolepsy. NUVIGIL is not approved for the treatment of bipolar disorders, depression or their associated symptoms.

The U.S. Food and Drug Administration-approved prescribing information for NUVIGIL, including a bolded warning, is available at www.NUVIGIL.com.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune 1000 and the S&P 500 Index, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota.

Cephalon has a growing presence in Europe, the Middle East and Africa. The Cephalon European headquarters and pre-clinical development center are located in Maisons-Alfort, France, just outside of Paris. Key business units are located in England, Ireland,
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
2. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
8. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
9. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
10. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
11. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... (NASDAQ: CYBX ) today announced results for the ... 1   Operating results for the first quarter ... 2014, and other achievements, include: , Worldwide net product ... Strong international net sales of $13.2 million, an increase of ... product sales reached a new high of $58.8 million, an ...
(Date:8/20/2014)... , Aug. 20, 2014 Northstar Global ... that after months of hard work from many ... new Snorenz formulation and package design.  The new ... B-6 back into the product due to overwhelming ... lasting effects.  Snorenz Nighttime will also include these ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Missouri blocked the sale ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
(Date:8/21/2014)... The City of Garden Grove is ... programming for its inaugural “Re:Imagine Garden Grove – A ... from 11 a.m. to 4 p.m., 2.85-miles of Garden ... the downtown will be filled with diverse music, dance, ... Resources (CARS), for all to enjoy. , The car-free ...
(Date:8/21/2014)... (HealthDay News) -- Black mothers are less likely than ... possible reason why: Hospitals in neighborhoods with many black ... areas with more white residents, a U.S. government study ... less common in medical centers where the black population ... for Disease Control and Prevention reported Thursday. These ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Not only is ... can save them hundreds of health-care dollars a year, a ... a professor of public health sciences at Wake Forest Baptist ... overweight and obese type 2 diabetes patients. ... randomly assigned to either an intensive "lifestyle change program" focused ...
(Date:8/21/2014)... (HealthDay News) -- Being born at a low birth weight ... a new study suggests. The findings may partly explain ... a high prevalence of low birth weight, the researchers added. ... that those with a low birth weight were 13 percent ... a normal birth weight. The risk of diabetes was 40 ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
Breaking Medicine News(10 mins):Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... adults in their late 30,s received a flu shot during ... study released today says. But about 65 percent were ... percent said they were following the issue very or moderately ... adults during the 2009-2010 H1N1 influenza epidemic, this second of ...
... Doheny HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... the risk of getting ovarian cancer, but new research shows ... surviving the deadly disease. Women with invasive epithelial ovarian ... women without the genetic variations, according to an analysis of ...
... practiced as part of routine care for people with ... pressure and cholesterol levels and keep them under control, ... February issue of Diabetes Care . Researchers ... cohort study of more than 30,000 people with diabetes ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Psychedelic ... suggest two small brain imaging studies that seem to ... mushrooms -- affects the brain. One study included ... blood while magnetic resonance imaging (MRI) scanners measured changes ...
... HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... and other signs of gastroesophageal reflux don,t get additional ... And, taking these medications when there are ... a respiratory infection, reports the study. "There,s a ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Obstetricians ... partner violence, including during prenatal visits, according to ... and Gynecologists. In addition, ob-gyns should offer ... on hand to give to patients who are ...
Cached Medicine News:Health News:Young adults responded well to swine flu 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 3Health News:Lifestyle counseling reduces time to reach treatment goals for people with diabetes 2Health News:Could 'Magic' Mushrooms Ease Depression? 2Health News:Could 'Magic' Mushrooms Ease Depression? 3Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 2Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 3Health News:Ob-Gyns Should Screen for Domestic Abuse: Experts 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: